GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (BUD:BAYER) » Definitions » Cyclically Adjusted PS Ratio

Bayer AG (BUD:BAYER) Cyclically Adjusted PS Ratio : 0.50 (As of May. 24, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Bayer AG Cyclically Adjusted PS Ratio?

As of today (2024-05-24), Bayer AG's current share price is Ft10796.00. Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was Ft21,696.00. Bayer AG's Cyclically Adjusted PS Ratio for today is 0.50.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted PS Ratio or its related term are showing as below:

BUD:BAYER' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.48   Med: 1.49   Max: 3.18
Current: 0.5

During the past years, Bayer AG's highest Cyclically Adjusted PS Ratio was 3.18. The lowest was 0.48. And the median was 1.49.

BUD:BAYER's Cyclically Adjusted PS Ratio is ranked better than
86.29% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.115 vs BUD:BAYER: 0.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer AG's adjusted revenue per share data for the three months ended in Mar. 2024 was Ft5,388.727. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is Ft21,696.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted PS Ratio Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.48 0.99 0.94 0.90 0.62

Bayer AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 0.92 0.83 0.62 0.52

Competitive Comparison of Bayer AG's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PS Ratio falls into.



Bayer AG Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bayer AG's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=10796.00/21696
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bayer AG's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5388.727/125.0381*125.0381
=5,388.727

Current CPI (Mar. 2024) = 125.0381.

Bayer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 5,933.523 99.543 7,453.256
201409 5,501.963 99.823 6,891.783
201412 5,702.894 99.543 7,163.556
201503 5,524.105 99.717 6,926.867
201506 5,733.000 100.417 7,138.687
201509 5,292.826 100.417 6,590.586
201512 5,255.423 99.717 6,589.957
201603 5,648.139 100.017 7,061.146
201606 5,688.813 100.717 7,062.559
201609 3,965.646 101.017 4,908.657
201612 3,878.013 101.217 4,790.696
201703 4,203.849 101.417 5,182.975
201706 3,913.700 102.117 4,792.166
201709 3,821.787 102.717 4,652.283
201712 4,064.649 102.617 4,952.742
201803 4,502.085 102.917 5,469.758
201806 4,279.834 104.017 5,144.743
201809 3,901.024 104.718 4,658.024
201812 4,250.712 104.217 5,099.925
201903 4,997.654 104.217 5,996.092
201906 4,362.855 105.718 5,160.192
201909 3,899.070 106.018 4,598.593
201912 4,301.978 105.818 5,083.381
202003 5,111.911 105.718 6,046.142
202006 4,077.779 106.618 4,782.295
202009 3,608.407 105.818 4,263.831
202012 4,379.341 105.518 5,189.508
202103 5,285.805 107.518 6,147.135
202106 4,709.876 108.486 5,428.489
202109 4,144.404 109.435 4,735.321
202112 4,524.610 110.384 5,125.301
202203 5,806.619 113.968 6,370.630
202206 4,880.460 115.760 5,271.608
202209 4,022.759 118.818 4,233.357
202212 4,578.329 119.345 4,796.732
202303 5,548.576 122.402 5,668.054
202306 4,309.456 123.140 4,375.868
202309 3,975.234 124.195 4,002.233
202312 4,658.932 123.773 4,706.555
202403 5,388.727 125.038 5,388.727

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (BUD:BAYER) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bayer AG Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (BUD:BAYER) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (BUD:BAYER) Headlines

No Headlines